{"schema_version":"secwatch.filing_event.v1","accession":"0000947871-26-000922","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2026-10-06T20:30:58+00:00","discovered_at":"2026-10-06T20:32:00.241955+00:00","generated_at":"2026-10-12T16:13:51.114679+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Quest Diagnostics EVP Catherine Doherty to retire July 2027, shifts to new EVP role Nov 1, 2026","bullets":["Catherine T. Doherty will retire in July 2027; effective November 1, 2026 she moves to Executive Vice President covering health systems, the Corewell Health joint venture, and Project Nova.","Base salary unchanged at $650,000; annual incentive target stays at 80% of base salary under the Senior Management Incentive Plan.","Committee approved an equity award with a November 3, 2026 grant date and $1,200,000 target value, allocated 100% to restricted stock units.","The equity award carries terms substantially the same as 2026 annual long-term incentive awards granted to other Quest senior executives.","Project Nova is described as the company's multi-year effort to modernize its 'Order to Cash' business processes, related IT infrastructure and enabling technologies."],"urls":{"canonical":"https://secwatch.observer/filing/0000947871-26-000922","json":"https://secwatch.observer/filing/0000947871-26-000922.json","markdown":"https://secwatch.observer/filing/0000947871-26-000922.md","text":"https://secwatch.observer/filing/0000947871-26-000922.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000094787126000922/0000947871-26-000922-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000094787126000922/ss6908054_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T16:13:51.114679+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"24a5e0a975","claim":"Catherine T. Doherty retired as Executive Vice President at QUEST DIAGNOSTICS INC.","evidence_excerpt":"On October 6, 2026, Quest Diagnostics Incorporated (the “Company”) announced that Catherine T. Doherty will retire in July 2027.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000094787126000922/0000947871-26-000922-index.htm","confidence":0.85,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Executive Vice President"}],"fact_type":"executive_change"},{"claim_id":"f621b33293","claim":"Catherine T. Doherty changed role as Executive Vice President at QUEST DIAGNOSTICS INC.","evidence_excerpt":"Until then, effective November 1, 2026, Ms. Doherty will transition to a new role as Executive Vice President with responsibilities including health systems, the Company’s joint venture with Corewell Health, and Project Nova, the Company’s multi-year project to modernize its “Order to Cash” business processes, which includes the related information technology infrastructure and underlying enabling technologies.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000094787126000922/0000947871-26-000922-index.htm","confidence":0.92,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned"},{"label":"Role","value":"Executive Vice President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}